AnaptysBio Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Pipeline Updates

NEXT STORY
Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization
PREV STORY
Capital Senior Living Corporation Reports Fourth Quarter and Full Year 2018 Results; Announces Changes to Senior Leadership
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

author_avatar
NASDAQ Market News

Caladrius Biosciences Reports Positive Full Results for CLBS16 from the ESCaPE-CMD Trial at SCAI 2020 Scientific Sessions

author_avatar
NASDAQ Market News

The European Medicines Agency accepts the regulatory submission for Lumoxiti in relapsed or refractory hairy cell leukemia

author_avatar
NASDAQ Market News